Geron Current Ratio 2006-2021 | GERN

Geron current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Geron Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.20B $0.04B 5.45
2021-03-31 $0.22B $0.03B 7.54
2020-12-31 $0.20B $0.03B 6.46
2020-09-30 $0.23B $0.02B 9.60
2020-06-30 $0.22B $0.02B 11.53
2020-03-31 $0.13B $0.02B 7.93
2019-12-31 $0.14B $0.03B 5.03
2019-09-30 $0.14B $0.01B 11.98
2019-06-30 $0.16B $0.01B 16.86
2019-03-31 $0.16B $0.01B 24.94
2018-12-31 $0.17B $0.01B 21.99
2018-09-30 $0.17B $0.00B 37.81
2018-06-30 $0.16B $0.01B 33.08
2018-03-31 $0.09B $0.00B 20.78
2017-12-31 $0.10B $0.01B 14.73
2017-09-30 $0.10B $0.01B 16.51
2017-06-30 $0.10B $0.01B 9.05
2017-03-31 $0.11B $0.01B 9.19
2016-12-31 $0.12B $0.01B 14.76
2016-09-30 $0.12B $0.01B 15.72
2016-06-30 $0.11B $0.01B 15.71
2016-03-31 $0.11B $0.01B 16.67
2015-12-31 $0.12B $0.01B 17.47
2015-09-30 $0.12B $0.01B 19.92
2015-06-30 $0.14B $0.04B 3.44
2015-03-31 $0.15B $0.04B 3.64
2014-12-31 $0.15B $0.04B 3.67
2014-09-30 $0.13B $0.01B 18.13
2014-06-30 $0.14B $0.01B 29.98
2014-03-31 $0.15B $0.01B 32.70
2013-12-31 $0.07B $0.01B 8.84
2013-09-30 $0.07B $0.01B 10.01
2013-06-30 $0.07B $0.01B 14.48
2013-03-31 $0.08B $0.01B 12.01
2012-12-31 $0.10B $0.01B 6.96
2012-09-30 $0.10B $0.01B 9.16
2012-06-30 $0.12B $0.01B 10.08
2012-03-31 $0.12B $0.01B 11.93
2011-12-31 $0.13B $0.01B 9.34
2011-09-30 $0.15B $0.01B 14.73
2011-06-30 $0.16B $0.01B 16.96
2011-03-31 $0.17B $0.01B 18.18
2010-12-31 $0.20B $0.04B 4.77
2010-09-30 $0.14B $0.01B 18.03
2010-06-30 $0.13B $0.01B 19.22
2010-03-31 $0.13B $0.01B 19.58
2009-12-31 $0.12B $0.01B 15.80
2009-09-30 $0.19B $0.01B 19.73
2009-06-30 $0.19B $0.01B 18.55
2009-03-31 $0.21B $0.01B 26.40
2008-12-31 $0.17B $0.01B 21.82
2008-09-30 $0.18B $0.01B 20.95
2008-06-30 $0.19B $0.01B 22.49
2008-03-31 $0.20B $0.01B 23.30
2007-12-31 $0.21B $0.01B 16.78
2007-09-30 $0.21B $0.01B 18.53
2007-06-30 $0.22B $0.01B 16.57
2007-03-31 $0.23B $0.01B 20.61
2006-12-31 $0.22B $0.05B 4.64
2006-09-30 $0.18B $0.01B 31.30
2006-06-30 $0.19B $0.01B 33.58
2006-03-31 $0.19B $0.01B 27.61
2005-12-31 $0.20B $0.02B 8.04
2005-09-30 $0.20B $0.01B 23.27
2005-06-30 $0.13B $0.01B 23.55
2005-03-31 $0.13B $0.01B 25.18
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.465B $0.000B
Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76